Biomarker aids diagnosis of metastatic breast cancer

03/14/2013 | PhysiciansBriefing.com

Circulating tumor DNA may be a better indicator of metastatic breast cancer than circulating tumor cells or cancer antigen 15-3. Circulating tumor DNA allowed for the detection of 29 of 30 cases, researchers said, and the biomarker provided the earliest measure of response to therapy. The research was reported in the New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC